Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST
SONN Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 |
Cash & Equivalents | 3.55 | 2.27 | 3.05 | 27.62 | 7.35 | 0.04 | Upgrade
|
Cash & Short-Term Investments | 3.55 | 2.27 | 3.05 | 27.62 | 7.35 | 0.04 | Upgrade
|
Cash Growth | -49.38% | -25.50% | -88.95% | 275.82% | 20515.10% | 557.93% | Upgrade
|
Other Receivables | 0.52 | 0.79 | 0.72 | - | - | - | Upgrade
|
Receivables | 0.52 | 0.79 | 0.72 | - | - | - | Upgrade
|
Prepaid Expenses | 1.05 | 1.68 | 1.64 | 1.19 | 0.29 | 0 | Upgrade
|
Total Current Assets | 5.13 | 4.74 | 5.41 | 28.81 | 7.64 | 0.04 | Upgrade
|
Property, Plant & Equipment | 0.17 | 0.23 | 0.3 | 0.18 | 0.27 | - | Upgrade
|
Long-Term Deferred Charges | 0.02 | 0.05 | 0.11 | - | - | - | Upgrade
|
Other Long-Term Assets | 0.49 | 0.41 | - | - | 0.08 | - | Upgrade
|
Total Assets | 5.8 | 5.43 | 5.83 | 28.99 | 7.99 | 0.04 | Upgrade
|
Accounts Payable | 1.88 | 2.2 | 4.75 | 3.78 | 2.06 | 1.84 | Upgrade
|
Accrued Expenses | 1.15 | 3.23 | 3.19 | 2.31 | 2.06 | 0.82 | Upgrade
|
Short-Term Debt | - | - | 0 | 0 | 0.02 | 0.22 | Upgrade
|
Current Portion of Leases | 0.08 | 0.07 | 0.05 | 0.09 | 0.08 | - | Upgrade
|
Current Unearned Revenue | - | 0.02 | 0.17 | 0.52 | 0.5 | - | Upgrade
|
Other Current Liabilities | 0 | 0 | 0 | - | - | - | Upgrade
|
Total Current Liabilities | 3.11 | 5.52 | 8.16 | 6.7 | 4.72 | 2.89 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.12 | - | Upgrade
|
Long-Term Leases | 0.07 | 0.13 | 0.2 | 0.03 | 0.13 | - | Upgrade
|
Total Liabilities | 3.18 | 5.66 | 8.37 | 6.73 | 4.97 | 2.89 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 117.17 | 110.02 | 88.87 | 83.95 | 39.72 | 9.59 | Upgrade
|
Retained Earnings | -114.55 | -110.24 | -91.41 | -61.69 | -36.71 | -12.44 | Upgrade
|
Shareholders' Equity | 2.62 | -0.23 | -2.54 | 22.26 | 3.02 | -2.85 | Upgrade
|
Total Liabilities & Equity | 5.8 | 5.43 | 5.83 | 28.99 | 7.99 | 0.04 | Upgrade
|
Total Debt | 0.15 | 0.2 | 0.26 | 0.13 | 0.35 | 0.22 | Upgrade
|
Net Cash (Debt) | 3.4 | 2.07 | 2.8 | 27.5 | 7 | -0.18 | Upgrade
|
Net Cash Growth | -49.94% | -25.98% | -89.83% | 292.99% | - | - | Upgrade
|
Net Cash Per Share | 1.18 | 15.95 | 113.31 | - | - | - | Upgrade
|
Filing Date Shares Outstanding | 0.68 | 0.38 | 0.05 | 0.02 | - | - | Upgrade
|
Total Common Shares Outstanding | 0.65 | 0.22 | 0.03 | 0.02 | - | - | Upgrade
|
Working Capital | 2.02 | -0.79 | -2.75 | 22.11 | 2.91 | -2.85 | Upgrade
|
Book Value Per Share | 4.01 | -1.03 | -80.59 | 910.35 | - | - | Upgrade
|
Tangible Book Value | 2.62 | -0.23 | -2.54 | 22.26 | 3.02 | -2.85 | Upgrade
|
Tangible Book Value Per Share | 4.01 | -1.03 | -80.59 | 910.35 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.